skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Leukemia Research remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia
Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia

Laughlin, Mary J. ; Rizzieri, David A. ; Smith, Clayton A. ; Moore, Joseph O. ; Lilly, Scott ; McGaughey, Dean ; Martin, P. ; Carrier, Carmellita ; Stevens, Cladd E. ; Rubinstein, Pablo ; Buckley, Rebecca ; Kurtzberg, Joanne

Leukemia research, 1998-03, Vol.22 (3), p.215-219 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Mitoxantrone and prolonged infusion gemcitabine as salvage therapy in patients with acute myelogenous leukemia
Mitoxantrone and prolonged infusion gemcitabine as salvage therapy in patients with acute myelogenous leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mitoxantrone and prolonged infusion gemcitabine as salvage therapy in patients with acute myelogenous leukemia

Apostolidou, Efrosyni ; Estey, Elihu ; Cortes, Jorge ; Garcia-Manero, Guillermo ; Faderl, Stefan ; Thomas, Deborah ; Tsimberidou, Apostolia ; Kantarjian, Hagop ; Giles, Francis J.

Leukemia research, 2003-04, Vol.27 (4), p.301-304 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Over-expression of Flt3 induces NF-κB pathway and increases the expression of IL-6
Over-expression of Flt3 induces NF-κB pathway and increases the expression of IL-6
Material Type:
Artigo 		Adicionar ao Meu Espaço

Over-expression of Flt3 induces NF-κB pathway and increases the expression of IL-6

Takahashi, Shinichiro ; Harigae, Hideo ; Ishii, Keiko Kumura ; Inomata, Mitsue ; Fujiwara, Tohru ; Yokoyama, Hisayuki ; Ishizawa, Kenichi ; Kameoka, Junichi ; Licht, Jonathan D. ; Sasaki, Takeshi ; Kaku, Mitsuo

Leukemia research, 2005-08, Vol.29 (8), p.893-899 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Inhibition of NF-κB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines
Inhibition of NF-κB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines
Material Type:
Artigo 		Adicionar ao Meu Espaço

Inhibition of NF-κB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines

García, Mariana G. ; Alaniz, Laura ; Lopes, Eloisi C. ; Blanco, Guillermo ; Hajos, Silvia E. ; Alvarez, Elida

Leukemia research, 2005-12, Vol.29 (12), p.1425-1434 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia
Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia

Xu, Wen-Lin ; Shen, Hui-Ling ; Ao, Zhong-Fang ; Chen, Bao-An ; Xia, Wei ; Gao, Feng ; Zhang, Yong-Ning

Leukemia research, 2006-04, Vol.30 (4), p.407-413 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
A phase II study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients with very high risk relapsed acute myeloid leukemia
A phase II study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients with very high risk relapsed acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients with very high risk relapsed acute myeloid leukemia

Giles, Francis ; Verstovsek, Srdan ; Faderl, Stefan ; Vey, Norbert ; Karp, Judy ; Roboz, Gail ; Khan, Khuda Dan ; Cooper, Maureen ; Bilgrami, Syed Fazl Ali ; Ferrant, Augustin ; Daenen, Simon ; Karsten, Verena ; Cahill, Ann ; Albitar, Maher ; Kantarjian, Hagop ; O’Brien, Susan ; Feldman, Eric

Leukemia research, 2006-12, Vol.30 (12), p.1591-1595 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
P129 A pilot study of decitabine in combination with arsenic trioxide for patients with myelodysplastic syndromes
P129 A pilot study of decitabine in combination with arsenic trioxide for patients with myelodysplastic syndromes
Material Type:
Artigo 		Adicionar ao Meu Espaço

P129 A pilot study of decitabine in combination with arsenic trioxide for patients with myelodysplastic syndromes

de Castro, C ; Adams, D ; Rizzieri, D ; Moore, J ; Gockerman, J ; Diehl, L ; Horwitz, M ; Edmonds, E ; Warzecho, J

Leukemia research, 2009-05, Vol.33, p.S134-S134 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
8
P134 A phase II pilot study of sorafenib in patients with myelodysplastic syndromes
P134 A phase II pilot study of sorafenib in patients with myelodysplastic syndromes
Material Type:
Artigo 		Adicionar ao Meu Espaço

P134 A phase II pilot study of sorafenib in patients with myelodysplastic syndromes

de Castro, C ; Adams, D ; Rizzieri, D ; Moore, J ; Gockerman, J ; Diehl, L ; Horwitz, M ; Edmonds, E ; Warzecho, J

Leukemia research, 2009-05, Vol.33, p.S137-S137 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Effect of cloretazine (VNP40101M) on acute myeloid leukaemia blast cells in vitro as a single agent and combined with cytarabine and daunorubicin
Effect of cloretazine (VNP40101M) on acute myeloid leukaemia blast cells in vitro as a single agent and combined with cytarabine and daunorubicin
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of cloretazine (VNP40101M) on acute myeloid leukaemia blast cells in vitro as a single agent and combined with cytarabine and daunorubicin

Morris, Karen L ; Adams, Julie A ; Liu Yin, John A

Leukemia research, 2009-08, Vol.33 (8), p.1096-1099 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Incorporating novel agents in the treatment of myelodysplastic syndromes
Incorporating novel agents in the treatment of myelodysplastic syndromes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Incorporating novel agents in the treatment of myelodysplastic syndromes

Anargyrou, Konstantinos ; Vassilakopoulos, Theodoros P ; Angelopoulou, Maria K ; Terpos, Evangelos

Leukemia research, 2010-01, Vol.34 (1), p.6-17 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.